Dossier
profit over America's health
Coverage of profit over America's health in the Nexus archive.
- Opinion: The U.S. pharmaceutical supply chain problem is not about China
The U.S. faced 216 active drug shortages in 2025, highlighting vulnerabilities in its pharmaceutical supply chain. The article argues that framing the issue as a U.S.-China competition distracts from the real cause: inadequate regulation leading to profit prioritization over public health.